Personal Finance

Indaptus Therapeutics : INDP

INDP

Stock Data

$2.52

$0.06 (2.44%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Indaptus Therapeutics Inc. is an innovative biotechnology company dedicated to developing advanced immunotherapies aimed at revolutionizing cancer treatment. Leveraging its proprietary platform that optimizes the immune system's ability to detect and eradicate tumor cells, Indaptus is committed to enhancing treatment effectiveness and patient outcomes. The firm's diverse pipeline of clinical candidates targets significant unmet needs in oncology, positioning it for strong growth amidst a competitive landscape. With a focus on scientific advancement and collaborations with premier research institutions, Indaptus is well-equipped to become a transformative player in the biopharmaceutical industry.